Expression of Reactive Oxygen Species–Related Transcripts in Egyptian Children With Autism

The molecular basis of the pathophysiological role of oxidative stress in autism is understudied. Herein, we used polymerase chain reaction (PCR) array to analyze transcriptional pattern of 84 oxidative stress genes in peripheral blood mononuclear cell pools isolated from 32 autistic patients (16 mild/moderate and 16 severe) and 16 healthy subjects (each sample is a pool from 4 autistic patients or 4 controls). The PCR array data were further validated by quantitative real-time PCR in 80 autistic children (55 mild/moderate and 25 severe) and 60 healthy subjects. Our data revealed downregulation in GCLM, SOD2, NCF2, PRNP, and PTGS2 transcripts (1.5, 3.8, 1.2, 1.7, and 2.2, respectively;P < .05 for all) in autistic group compared with controls. In addition, TXN and FTH1 exhibited 1.4- and 1.7-fold downregulation, respectively, in severe autistic patients when compared with mild/moderate group (P = .005 and .0008, respectively). This study helps in a better understanding of the underlying biology and related genetic factors of autism, and most importantly, it presents suggested candidate biomarkers for diagnosis and prognosis purposes as well as targets for therapeutic intervention.

[1]  Kyle Sterrett,et al.  An Item Response Theory Evaluation of the Autism Diagnostic Interview-Revised (ADI-R) , 2019 .

[2]  H. Yamada,et al.  Reduced endogenous urinary total antioxidant power and its relation of plasma antioxidant activity of superoxide dismutase in individuals with autism spectrum disorder , 2017, International Journal of Developmental Neuroscience.

[3]  Paul J Thornalley,et al.  Quantitation of plasma thiamine, related metabolites and plasma protein oxidative damage markers in children with autism spectrum disorder and healthy controls , 2016, Free radical research.

[4]  P. Young,et al.  Identification of human ferritin, heavy polypeptide 1 (FTH1) and yeast RGI1 (YER067W) as pro-survival sequences that counteract the effects of Bax and copper in Saccharomyces cerevisiae. , 2016, Experimental cell research.

[5]  D. Wall,et al.  A common molecular signature in ASD gene expression: following Root 66 to autism , 2016, Translational psychiatry.

[6]  E. Kılıç,et al.  Cellular prion protein promotes post-ischemic neuronal survival, angioneurogenesis and enhances neural progenitor cell homing via proteasome inhibition , 2015, Cell Death and Disease.

[7]  V. Balachandar,et al.  REMOVED: Peripheral blood markers of homocysteine, paraoxonase1 (PON1) activity and oxidative stress in autism , 2015, International Journal of Developmental Neuroscience.

[8]  V. Suganya,et al.  Urine proteome analysis to evaluate protein biomarkers in children with autism. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[9]  W. Zou,et al.  Cellular prion protein (PrP(C)) and its role in stress responses. , 2015, International journal of clinical and experimental medicine.

[10]  Yiping Shen,et al.  Autistic Children Exhibit Decreased Levels of Essential Fatty Acids in Red Blood Cells , 2015, International journal of molecular sciences.

[11]  J. Bressler,et al.  Interaction between GSTT1 and GSTP1 allele variants as a risk modulating-factor for autism spectrum disorders. , 2015, Research in autism spectrum disorders.

[12]  Si-ju Gao,et al.  Thioredoxin: A novel, independent diagnosis marker in children with autism , 2015, International Journal of Developmental Neuroscience.

[13]  Jaleel A. Miyan,et al.  Brain-immune interactions in health and disease , 2014, Front. Neurosci..

[14]  I. Hertz-Picciotto,et al.  Deficits in Bioenergetics and Impaired Immune Response in Granulocytes From Children With Autism , 2014, Pediatrics.

[15]  A. Chauhan,et al.  Impaired synthesis and antioxidant defense of glutathione in the cerebellum of autistic subjects: alterations in the activities and protein expression of glutathione-related enzymes. , 2013, Free radical biology & medicine.

[16]  S. Kothare,et al.  Relationship of serum ferritin levels to sleep fragmentation and periodic limb movements of sleep on polysomnography in autism spectrum disorders. , 2013, Pediatric neurology.

[17]  A. Legido,et al.  Mitochondrial dysfunction in autism. , 2013, Seminars in pediatric neurology.

[18]  S. J. James,et al.  Redox metabolism abnormalities in autistic children associated with mitochondrial disease , 2013, Translational Psychiatry.

[19]  S. Dimauro,et al.  Mitochondrial abnormalities in temporal lobe of autistic brain , 2013, Neurobiology of Disease.

[20]  O. Hwang Role of Oxidative Stress in Parkinson's Disease , 2013, Experimental neurobiology.

[21]  A. Kovács,et al.  Blood lipid peroxidation, antioxidant enzyme activities and hemorheological changes in autistic children. , 2013, Ideggyogyaszati szemle.

[22]  Y. Jeng,et al.  Loss of the oxidative stress sensor NPGPx compromises GRP78 chaperone activity and induces systemic disease. , 2012, Molecular cell.

[23]  Patricia L. A. Leighton,et al.  Amyloid Beta Precursor Protein and Prion Protein Have a Conserved Interaction Affecting Cell Adhesion and CNS Development , 2012, PloS one.

[24]  A. El-Ansary,et al.  Lipid mediators in plasma of autism spectrum disorders , 2012, Lipids in Health and Disease.

[25]  B. Kumar,et al.  Drug therapy in autism: a present and future perspective , 2012, Pharmacological reports : PR.

[26]  Susan L. Johnson,et al.  Iron Status in Children With Autism Spectrum Disorder , 2012, Pediatrics.

[27]  Robert A Harris,et al.  Mutations in BCKD-kinase Lead to a Potentially Treatable Form of Autism with Epilepsy , 2012, Science.

[28]  J. D. del Río,et al.  Unraveling the neuroprotective mechanisms of PrPC in excitotoxicity , 2012, Prion.

[29]  Stefano Bonassi,et al.  Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. , 2012, Free radical biology & medicine.

[30]  N. Meguid,et al.  PREVALENCE OF CONSANGUINEOUS MARRIAGES IN SOUTH SINAI, EGYPT , 2012, Journal of Biosocial Science.

[31]  M. Fenech,et al.  The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis , 2012, Nutrition & Metabolism.

[32]  David Wallinga,et al.  A macroepigenetic approach to identify factors responsible for the autism epidemic in the United States , 2012, Clinical Epigenetics.

[33]  D. Gaylor,et al.  Metabolic Imbalance Associated with Methylation Dysregulation and Oxidative Damage in Children with Autism , 2012, Journal of autism and developmental disorders.

[34]  W. El-Rifai,et al.  Glutathione peroxidase 7 protects against oxidative DNA damage in oesophageal cells , 2011, Gut.

[35]  A. El-Ansary,et al.  Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia , 2011, BMC neurology.

[36]  N. Meguid,et al.  Evaluation of Oxidative Stress in Autism: Defective Antioxidant Enzymes and Increased Lipid Peroxidation , 2011, Biological Trace Element Research.

[37]  Lakshmi Priya Malarveni Damodaran,et al.  Urinary oxidative stress markers in children with autism , 2011, Redox report : communications in free radical research.

[38]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[39]  H. Chung,et al.  Molecular Inflammation as an Underlying Mechanism of the Aging Process and Age-related Diseases , 2011, Journal of dental research.

[40]  C. Chu,et al.  Nuclear transport, oxidative stress, and neurodegeneration. , 2011, International journal of clinical and experimental pathology.

[41]  Javaneh Tamiji,et al.  The Neurobiology of Lipid Metabolism in Autism Spectrum Disorders , 2011, Neurosignals.

[42]  D. Rossignol,et al.  Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis , 2011, Molecular Psychiatry.

[43]  Felix W Wehrli,et al.  MRI Estimation of Global Brain Oxygen Consumption Rate , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[44]  A. El-Ansary,et al.  Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. , 2009, Clinical biochemistry.

[45]  Paolo Zamboni,et al.  Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options , 2009, Current neuropharmacology.

[46]  M. Georgieff The role of iron in neurodevelopment: fetal iron deficiency and the developing hippocampus. , 2008, Biochemical Society transactions.

[47]  B. Vandermeer,et al.  Behavioural and Developmental Interventions for Autism Spectrum Disorder: A Clinical Systematic Review , 2008, PloS one.

[48]  G. Baird,et al.  Autistic symptomatology and language ability in autism spectrum disorder and specific language impairment. , 2008, Journal of child psychology and psychiatry, and allied disciplines.

[49]  J. Connor,et al.  Ferritin: a novel mechanism for delivery of iron to the brain and other organs. , 2007, American journal of physiology. Cell physiology.

[50]  J. Brian,et al.  Ferritin as an indicator of suspected iron deficiency in children with autism spectrum disorder: prevalence of low serum ferritin concentration. , 2006, Developmental medicine and child neurology.

[51]  J. Gregg,et al.  Utilization of Lymphoblastoid Cell Lines as a System for the Molecular Modeling of Autism , 2006, Journal of autism and developmental disorders.

[52]  P. Ashwood,et al.  The immune response in autism: a new frontier for autism research , 2006, Journal of leukocyte biology.

[53]  Bryan Frank,et al.  Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes , 2006, BMC Genomics.

[54]  S. Karande Autism: A review for family physicians. , 2006, Indian journal of medical sciences.

[55]  Irva Hertz-Picciotto,et al.  The CHARGE Study: An Epidemiologic Investigation of Genetic and Environmental Factors Contributing to Autism , 2006, Environmental health perspectives.

[56]  C. Jee,et al.  Thioredoxin is related to life span regulation and oxidative stress response in Caenorhabditis elegans , 2005, Genes to cells : devoted to molecular & cellular mechanisms.

[57]  J. Szaflarski,et al.  Human blood genomics: distinct profiles for gender, age and neurofibromatosis type 1. , 2004, Brain research. Molecular brain research.

[58]  B. Wigdahl,et al.  Human T-cell leukemia virus type I Tax induces the expression of dendritic cell markers associated with maturation and activation , 2004, Journal of NeuroVirology.

[59]  A. Hershey,et al.  Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and down's syndrome , 2004, Annals of neurology.

[60]  David W Gaylor,et al.  Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. , 2004, The American journal of clinical nutrition.

[61]  W. McGinnis Oxidative stress in autism. , 2004, Alternative therapies in health and medicine.

[62]  K. Desai,et al.  Identification of a Novel Putative Non-selenocysteine Containing Phospholipid Hydroperoxide Glutathione Peroxidase (NPGPx) Essential for Alleviating Oxidative Stress Generated from Polyunsaturated Fatty Acids in Breast Cancer Cells* , 2004, Journal of Biological Chemistry.

[63]  S. Zoroglu,et al.  Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism , 2004, European Archives of Psychiatry and Clinical Neuroscience.

[64]  H. Schipper Redox Neurology: Visions of an Emerging Subspecialty , 2004, Annals of the New York Academy of Sciences.

[65]  S. Nanko,et al.  Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder , 2003, Nature Genetics.

[66]  C. Haase,et al.  Treatment of an Immortalized APC Cell Line with Both Cytokines and LPS Ensures Effective T‐Cell Activation In Vitro , 2002, Scandinavian journal of immunology.

[67]  O. Yorbik,et al.  Investigation of antioxidant enzymes in children with autistic disorder. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[68]  R. Cook,et al.  Iron Deficiency in Autism and Asperger Syndrome , 2002, Autism : the international journal of research and practice.

[69]  E. London The environment as an etiologic factor in autism: a new direction for research. , 2000, Environmental health perspectives.

[70]  R. Mulcahy,et al.  Cloning and sequencing of the cDNA for the light subunit of human liver gamma-glutamylcysteine synthetase and relative mRNA levels for heavy and light subunits in human normal tissues. , 1995, Biochemical and biophysical research communications.

[71]  T. Hla,et al.  Human cyclooxygenase-2 cDNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[72]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[73]  Amit Kunwar,et al.  Free radicals, oxidative stress and importance of antioxidants in human health - , 2011 .

[74]  J. Gregg,et al.  Gene expression changes in children with autism. , 2008, Genomics.

[75]  R. Weisinger,et al.  The role of eicosanoids in the brain. , 2008, Asia Pacific journal of clinical nutrition.

[76]  Kit Shan Lee,et al.  Iron deficiency. , 1992, The New Zealand medical journal.